Intuitive Surgical (ISRG) Fundamental Analysis: Revenue, Earnings & Valuation

9.12 / 10

Outperform

Fundamentally, ISRG scores 9.12/10, earning an Outperform rating. Key strengths include PB‑ROE, ROA, diluted ROE, profit‑to‑MV and a 26% YoY cash‑flow growth, all in top quartile. Weak points are high current‑liabilities ratio and modest asset‑MV, dragging the overall score slightly.

Analysis Checks(7/10)

Revenue-MV

Value-1.50

Score3/3

Weight39.35%

1M Return5.11%

ROA (%)

Value14.68

Score3/3

Weight15.91%

1M Return2.03%

Net cash flow from operating activities per share (YoY growth rate %)

Value26.03

Score3/3

Weight11.46%

1M Return1.58%

Current liabilities / Total liabilities (%)

Value79.71

Score0/3

Weight-22.31%

1M Return-4.34%

Profit-MV

Value-0.12

Score2/3

Weight17.70%

1M Return2.14%

PB-ROE

Value8.86

Score3/3

Weight26.37%

1M Return3.49%

Annualized net profit margin on total assets (%)

Value14.68

Score3/3

Weight15.91%

1M Return2.03%

ROE (diluted) (%)

Value16.02

Score3/3

Weight16.52%

1M Return2.11%

Asset-MV

Value-0.55

Score0/3

Weight-11.63%

1M Return-1.77%

Net profit / Total profit (%)

Value86.87

Score1/3

Weight-9.31%

1M Return-1.34%

Is ISRG undervalued or overvalued?

ISRG scores 9.12/10 on fundamentals and holds a Discounted valuation at present. Backed by its 16.57% ROE, 28.58% net margin, 58.45 P/E ratio, 9.30 P/B ratio, and 22.32% earnings growth, these metrics solidify its Outperform investment rating.